We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
+14.69%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.91B
AUM Growth
+$603M
Cap. Flow
+$14.5M
Cap. Flow %
0.29%
Top 10 Hldgs %
23.21%
Holding
1,377
New
62
Increased
512
Reduced
253
Closed
35

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$12.4M
2
MSFT icon
Microsoft
MSFT
+$9.88M
3
OGE icon
OGE Energy
OGE
+$9.67M
4
VZ icon
Verizon
VZ
+$9.67M
5
ALLY icon
Ally Financial
ALLY
+$8.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.1M
2
CI icon
Cigna
CI
+$18M
3
ALL icon
Allstate
ALL
+$13.6M
4
BA icon
Boeing
BA
+$11.6M
5
IFF icon
International Flavors & Fragrances
IFF
+$11M

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Financials 14.44%
3 Healthcare 13.82%
4 Consumer Discretionary 13.32%
5 Industrials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALTR
1301
DELISTED
Altair Engineering Inc
ALTR
$25K ﹤0.01%
680
+34
+5% +$1.14K
CHRS icon
1302
Coherus Oncology
CHRS
$181M
$24K ﹤0.01%
1,782
+374
+27% +$4.99K
GPMT
1303
Granite Point Mortgage Trust
GPMT
$58.8M
$24K ﹤0.01%
+1,296
New +$24.5K
XPH icon
1304
State Street SPDR S&P Pharmaceuticals ETF
XPH
$510M
$24K ﹤0.01%
+576
New +$23.4K
CCJ icon
1305
Cameco
CCJ
$43.1B
$23K ﹤0.01%
1,984
– –
SNDX icon
1306
Syndax Pharmaceuticals
SNDX
$1.77B
$23K ﹤0.01%
4,352
-850
-16% -$4.85K
MRTX
1307
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$23K ﹤0.01%
+308
New +$21K
OBSV
1308
DELISTED
ObsEva SA Ordinary Shares
OBSV
$23K ﹤0.01%
1,764
– –
MEOH icon
1309
Methanex
MEOH
$4.17B
$22K ﹤0.01%
396
– –
SLP icon
1310
Simulations Plus
SLP
$371M
$22K ﹤0.01%
+1,054
New +$21.1K
BOX icon
1311
Box
BOX
$4.48B
$21K ﹤0.01%
1,064
+56
+6% +$1.16K
BB icon
1312
BlackBerry
BB
$5.14B
$20K ﹤0.01%
2,024
– –
ECOM
1313
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$20K ﹤0.01%
1,652
+84
+5% +$1K
ARRY
1314
DELISTED
Array Biopharma Inc
ARRY
$20K ﹤0.01%
814
+550
+208% +$11.5K
SAP icon
1315
SAP
SAP
$236B
$19K ﹤0.01%
168
– –
INXN
1316
DELISTED
Interxion Holding N.V.
INXN
$19K ﹤0.01%
286
– –
FIVN icon
1317
FIVE9
FIVN
$2.33B
$18K ﹤0.01%
336
+16
+5% +$813
ICL icon
1318
ICL Group
ICL
$7.06B
$18K ﹤0.01%
3,500
– –
QTWO icon
1319
Q2 Holdings
QTWO
$3.9B
$18K ﹤0.01%
264
– –
KALV
1320
DELISTED
KalVista Pharmaceuticals
KALV
$17K ﹤0.01%
608
– –
CBAY
1321
DELISTED
Cymabay Therapeutics
CBAY
$17K ﹤0.01%
1,264
– –
RETA
1322
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$17K ﹤0.01%
196
-56
-22% -$4.65K
ELLI
1323
DELISTED
Ellie Mae Inc
ELLI
$17K ﹤0.01%
176
+16
+10% +$1.39K
BMRN icon
1324
BioMarin Pharmaceuticals
BMRN
$13.6B
$16K ﹤0.01%
+176
New +$16.3K
KGC icon
1325
Kinross Gold
KGC
$32.6B
$16K ﹤0.01%
4,818
– –
51 52
53
54 55

Similar funds

FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
EP
Elkfork Partners Portland, Oregon $4.11B AUM 5.26% 1-Year Est. Return
MIH
Madison Investment Holdings Madison, Wisconsin $6.16B AUM 11.67% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Meadow Creek Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Meadow Creek Investment Management held 1,377 positions worth $4.91B, up 14% from $4.31B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meadow Creek Investment Management's Q1 2019 filing shows 62 new, 512 increased, 253 reduced and 35 closed positions. Its largest new stake was Celanese: 49,308 shares worth $4.86M. The largest sale was Celgene Corp, an estimated $25.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Meadow Creek Investment Management's largest Q1 2019 buy was Celanese: 49,308 shares worth $4.86M.
  • Meadow Creek Investment Management added most to Eaton in Q1 2019, an estimated $12.4M increase.
  • Meadow Creek Investment Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $25.1M.
  • Meadow Creek Investment Management fully exited VICI Properties in Q1 2019, selling an estimated $2.71M.
  • Meadow Creek Investment Management's ten largest holdings make up 23% of its $4.91B portfolio in Q1 2019.
  • Meadow Creek Investment Management opened 62 new positions and closed 35 in Q1 2019.
  • Meadow Creek Investment Management's portfolio value rose 14% quarter-over-quarter to $4.91B.

Based on Meadow Creek Investment Management's 13F filing for Q1 2019, filed 13 May 2019.